Cargando…

Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance

Detalles Bibliográficos
Autores principales: Lu, Jinmiao, Ying, Xiaohua, Li, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461880/
https://www.ncbi.nlm.nih.gov/pubmed/37579370
http://dx.doi.org/10.34172/ijhpm.2023.7972
_version_ 1785097929421225984
author Lu, Jinmiao
Ying, Xiaohua
Li, Zhiping
author_facet Lu, Jinmiao
Ying, Xiaohua
Li, Zhiping
author_sort Lu, Jinmiao
collection PubMed
description
format Online
Article
Text
id pubmed-10461880
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Kerman University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-104618802023-08-29 Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance Lu, Jinmiao Ying, Xiaohua Li, Zhiping Int J Health Policy Manag Letter to Editor Kerman University of Medical Sciences 2023-06-18 /pmc/articles/PMC10461880/ /pubmed/37579370 http://dx.doi.org/10.34172/ijhpm.2023.7972 Text en © 2023 The Author(s); Published by Kerman University of Medical Sciences https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to Editor
Lu, Jinmiao
Ying, Xiaohua
Li, Zhiping
Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance
title Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance
title_full Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance
title_fullStr Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance
title_full_unstemmed Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance
title_short Pricing New Drugs for COVID-19 in the Pharmaceutical Industry: Insights From the Chinese Medical Insurance
title_sort pricing new drugs for covid-19 in the pharmaceutical industry: insights from the chinese medical insurance
topic Letter to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461880/
https://www.ncbi.nlm.nih.gov/pubmed/37579370
http://dx.doi.org/10.34172/ijhpm.2023.7972
work_keys_str_mv AT lujinmiao pricingnewdrugsforcovid19inthepharmaceuticalindustryinsightsfromthechinesemedicalinsurance
AT yingxiaohua pricingnewdrugsforcovid19inthepharmaceuticalindustryinsightsfromthechinesemedicalinsurance
AT lizhiping pricingnewdrugsforcovid19inthepharmaceuticalindustryinsightsfromthechinesemedicalinsurance